Lara Krüger

Dr. Lara Krüger


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
LKLara Krüger
Lara Krüger
ASAndré Strahl
André Strahl
EGEva Goedecke
Eva Goedecke
MDMaximilian M. Delsmann
Maximilian M. Delsmann
LKLeon-Gordian Koepke
Leon-Gordian Koepke
JHJan Hubert
Jan Hubert
(1) Background: The aim of this study was to evaluate the safety of intraoperative cell salvage (ICS) during reimplantation in the two-stage revision of septic hip arthroplasties. (2) Methods: As part of an internal quality control study, blood cultures were taken from the processed ICS blood during reimplantation and examined for possible bacterial load (study group). Due to a high rate of bacterial detection with uncertain clinical significance, consecutive ICS samples were also examined from patients undergoing aseptic revision hip arthroplasty (control group). Microbiological samples, patient and surgical characteristics and the follow-up data were analyzed retrospectively. (3) Results: 9 out of 12 (75%) patients in the study group and 5 out of 8 (63%) patients in the control group had positive ICS blood cultures. There was no significant difference between the groups (p = 0.642). The initial pathogens causing the periprosthetic joint infection (PJI) were not detected, but the bacterial spectrum resembled skin flora, with a high proportion of coagulase-negative staphylococci. No complications due to possible bloodstream-associated infections were observed. In summary, the detected pathogens were interpreted as contamination without clinical significance. (4) Conclusions: ICS in the context of reimplantation was considered a safe and recommendable procedure to optimize patient blood management.

8 April 2021 in Der Orthopäde
Verified
Journal Article
Open access
PDF file
RTRuth Thiemann
Ruth Thiemann
HSHans-Werner Seide
Hans-Werner Seide
KLKlaus-Dieter Luitjens
Klaus-Dieter Luitjens
FBFrank Timo Beil
Frank Timo Beil
TRTim Rolvien
Tim Rolvien
LKLara Krüger
Lara Krüger
Zusammenfassung: Hintergrund: Osteoidosteome zählen zu den benignen ossären Neoplasien und können am gesamten Skelett auftreten. Die verlängerte Diagnosestellung eines Osteoidosteoms der Großzehe veranlasste uns, einen Fallbericht mit Review der Literatur zu verfassen, um mögliche Fehlerquellen zu identifizieren und einen Beitrag zur zügigeren Diagnosefindung und Therapie zu leisten. Literatur: In der deutschen Literatur sind aktuell nur zwei Fallberichte zu Osteoidosteomen der Zehen bekannt. International wurde allerdings eine Vielzahl an Fällen beschrieben, die in der Zusammenschau ein homogenes Bild ergeben. Eine sehr deutliche Häufung von Osteoidosteomen am Endglied der Großzehe lassen eine posttraumatische Ätiologie möglich erscheinen. Der typische NSAR-sensible Nachtschmerz ist klinisch eindeutig und sollte an jeder Lokalität des Körpers an ein Osteoidosteom denken lassen. Auffällig ist das an den Zehen einzigartige Symptom der Makrodaktylie, was ein dankbarer Hinweis zur Diagnosefindung sein kann. Die mittlere Zeit vom Symptombeginn bis zur korrekten Diagnosestellung betrug 12 Monate. Häufig wurden Fehldiagnosen und Fehltherapien unter einer anderen Verdachtsdiagnose beschrieben. Eine mögliche Ursache ist die häufig atypische und uneindeutige Bildgebung. Die operative Therapie stellt bei Osteoidosteomen der Zehen die Methode der Wahl dar und sollte stets durch eine histopathologische Untersuchung ergänzt werden.

22 June 2022 in Foot and Ankle Surgery
Verified
Journal Article
Closed access
LKLara Krüger
Lara Krüger
TRTim Rolvien
Tim Rolvien
MSMarcel Seller
Marcel Seller
JHJan Hubert
Jan Hubert
FBFrank Timo Beil
Frank Timo Beil
ASAndré Strahl
André Strahl

30 May 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
LKLara Krüger
Lara Krüger
ASAndré Strahl
André Strahl
LKLeon-Gordian Koepke
Leon-Gordian Koepke
BFBernd Fink
Bernd Fink
FBFrank Timo Beil
Frank Timo Beil
JHJan Hubert
Jan Hubert
(1) Background: intraoperative cell salvage (ICS) devices can provide a valuable contribution to patient blood management. An infection of the surgical site presents a formal contraindication to the use of ICS. To date, there is no recommendation for the use of ICS in the context of reimplantation in two-stage septic exchange arthroplasty. (2) Methods: at two hospitals of maximum endoprosthetic care, a retrospective evaluation of patients who had received ICS blood during reimplantation of hip arthroplasties was performed. Patients’ and surgical characteristics, intraoperative cultures, and the occurrence of septic complications in the short- and long-term follow-up were recorded. (3) Results: 144 patients were included. Detection of positive cultures during reimplantation occurred in 13 cases. A total of 127 patients showed no complication, 8 patients showed a non-specific septic complication, 6 patients a local persistence of infection, and 3 patients a possible bloodstream-associated infection. No significant correlation was found between the occurrence of complications and the detection of positive intraoperative cultures. (4) Conclusions: no clustering of septic complications due to the use of ICS during reimplantation was found. In the risk-benefit analysis, we considered the use of ICS during reimplantation to be indicated in terms of patient blood management, while the safety of the procedure during septic first-stage resection arthroplasty or septic one-stage exchange arthroplasty was not investigated. Given the paucity of comparative literature, further studies are needed on ideal patient blood management in the setting of septic revision arthroplasty.

25 April 2024 in Cancers
Verified
Journal Article
Open access
PDF file
LKLeon-Gordian Koepke
Leon-Gordian Koepke
AHAnnika Heuer
Annika Heuer
MSMartin Stangenberg
Martin Stangenberg
MSMalte Schroeder
Malte Schroeder
GSGabriel Schmidt
Gabriel Schmidt
AAAnne Marie Asemissen
Anne Marie Asemissen
Malignant spinal lesions (MSLs) are frequently the first manifestation of malignant disease. Spinal care, diagnostic evaluation, and the initiation of systemic therapy are crucial for outcomes in patients (pts) with advanced cancer. However, histopathology (HP) may be time consuming. The additional evaluation of spinal lesions using cytopathology (CP) has the potential to reduce the time to diagnosis (TTD) and time to therapy (TTT). CP and HP specimens from spinal lesions were evaluated in parallel in 61 pts (CP/HP group). Furthermore, 139 pts in whom only HP was performed were analyzed (HP group). We analyzed the TTD of CP and HP within the CP/HP group. Furthermore, we compared the TTD and TTT between the groups. The mean TTD in CP was 1.7 ± 1.7 days (d) and 8.4 ± 3.6 d in HP (p < 0.001). In 13 pts in the CP/HP group (24.1%), specific therapy was initiated based on the CP findings in combination with imaging and biomarker results before completion of HP. The mean TTT in the CP/HP group was 21.0 ± 15.8 d and was significantly shorter compared to the HP group (28.6 ± 23.3 d) (p = 0.034). Concurrent CP for MSLs significantly reduces the TTD and TTT. As a result, incorporating concurrent CP for analyzing spinal lesions suspected of malignancy might have the potential to enhance pts’ quality of life and prognosis in advanced cancer. Therefore, we recommend implementing CP as a standard procedure for the evaluation of MSLs.

9 December 2025 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Open access
PDF file
LKLara Krüger
Lara Krüger
ASAlexander Simon
Alexander Simon
EGEva Goedecke
Eva Goedecke
CSCarsten W Schlickewei
Carsten W Schlickewei
TSTanja Spethmann
Tanja Spethmann
TRTim Rolvien
Tim Rolvien
Introduction: Given the inconclusive evidence regarding the effects of foot orthoses in flatfoot management, this study aimed to assess the impact of two distinct types of foot orthoses on three-dimensional bone alignment of the foot using advanced imaging techniques. Materials and methods: Sixteen fresh-frozen cadaveric feet showing radiological signs of progressive collapsing foot deformity were collected. Two different types of foot orthoses, type I with medial support and lateral counter-support and type II with an additional metatarsal pad, were custom-made. The feet were loaded using a testing machine and scanned by weight-bearing computed tomography. Semi-automatic 3D models of bone dimensions and axes were generated to compute the foot alignment. This study was designed according to the QUACS scale. Results: The sagittal talus-first metatarsal angle was corrected by an average of 2.0±3.0 degrees with type I orthoses ( p = 0.019), and 2.6±3.7 degrees with type II orthoses ( p = 0.018). The axial talocalcaneal angle was corrected by an average 1.8±2.8 degrees with type I orthoses ( p = 0.021), and 2.0±3.1 degrees with type II orthoses ( p = 0.02). The axial talus-first metatarsal angle was corrected by an average 1.3±2.0 degrees with type I orthoses ( p = 0.024), while type II orthoses caused no significant effect ( p = 0.297). No significant differences were found between type I and type II orthoses (all p > 0.05). Conclusions: In this cadaveric study, foot orthoses with medial support, with or without a metatarsal pad, improved all angles tested, but the effect appeared to be small. It remains to be determined whether these subtle changes are responsible for the positive clinical effects described in other studies, or whether orthoses have a positive effect even without reaching the intended alignment correction.